Aragen Life Sciences vs Proone Labs

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aragen/proonelabs

Category	Aragen Life Sciences	Proone Labs
Listed site	cro	cro
Summary	Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.	Proone Labs provides preclinical pharmacology, drug discovery, and regulatory support services to biotech startups, traditional pharma, and in-silico companies. The team has delivered 30+ assays, 50+ cell lines, and supported 4 FDA drug approvals across multiple therapeutic areas.
Services	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Carcinogenicity Studies DART (Reproductive & Developmental Toxicology) Specialized & Large-Animal Models Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies Translational Research US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Regulatory Affairs	Discovery Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry Computational & In-Silico Drug Discovery Protein Engineering Preclinical In Vitro Studies In Vitro Pharmacology In Vitro ADME / DMPK In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Bioanalysis Ligand-Binding Bioanalysis (Large Molecule) Analytical Method Development & Validation Regulatory Affairs US FDA Regulatory Strategy Translational Research
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Oligonucleotide mRNA Cell Therapy Gene Therapy Peptide Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Antibody-Drug Conjugate (ADC) Cell Therapy
Indications	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health	Neurology Gastroenterology Immunology
Locations	Global Headquarters, Hyderabad, Telangana, India R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Hyderabad, Telangana, India Manufacturing Campus, Visakhapatnam, Andhra Pradesh, India R&D Campus, Bengaluru, Karnataka, India Biosafety Solutions, Pune, Maharashtra, India Regional Office, New Delhi, Delhi, India Sales Office, Tokyo, Japan Sales Office, Seoul, South Korea Sales Office, Cambridge, Massachusetts, USA R&D Campus, Morgan Hill, California, USA Sales Office, Utrecht, Netherlands Sales Office, Milan, Italy Sales Office, South Korea Global Headquarters & R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Pune, Maharashtra, India R&D Campus, New Delhi, Delhi, India Sales Office, New Jersey, New Jersey, USA Global Headquarters, R&D and Manufacturing Campus, Hyderabad, Telangana, India R&D Campus, Mallapur, Hyderabad, India	Data not yet provided.
Certifications	USFDA · Identifier: EIR for Nacharam Unit 1	GLP · Identifier: GLP-compliant
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.